Adamas Pharmaceuticals

United States
Emeryville, California, United States, 94608

Company profile

Adamas Pharmaceuticals company profile

Adamas Pharmaceuticals, Inc. engages in the development and commercialization of controlled release combination therapeutics to treat healthcare problems, primarily in the areas of infectious diseases and central nervous system disorders. It also develops novel extended release and combination products for symptomatic treatment of dementia. The company was incorporated in 2000 and is headquartered in Emeryville, California with operations in India, the United States, and Singapore.

Business identity

Contact email
[email protected]
Phone number
5104280519
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2000-01-01, Year

Headquarters

Postal code
94608
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
9
Total equity funding
$383.2M
Last funding
Post IPO Equity / $59.2M / 2021-03-01
Last equity funding
Post IPO Equity / $59.2M
Investors
4
Lead investors
3
Founders
1
Articles
47
Exited on
2014-04-11

Founders and investors

Founders

Greg Went

Lead investors

Aeris CapitalDAG VenturesMohr Davidow Ventures

Investors

Aeris CapitalDAG VenturesMohr Davidow VenturesNorthgate Capital